Problem statement: Answer the MCQ question.
Query: Which drug exhibits a 3.925% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] Cn1c(-c2ccc(Cl)cc2)cnc1N
[b] CCNC(=O)NC(=O)C(C)Oc1ccc(C(=O)OC)cc1
[c] CN(C)S(=O)(=O)c1ccc(-c2csc(N/N=C/c3ccco3)n2)cc1
Answer: b. CCNC(=O)NC(=O)C(C)Oc1ccc(C(=O)OC)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCNC(=O)NC(=O)C(C)Oc1ccc(C(=O)OC)cc1
CCNC(=O)NC(=O)C(C)Oc1ccc(C(=O)OC)cc1
methyl 4-[1-(ethylcarbamoylamino)-1-oxopropan-2-yl]oxybenzoate